Cargando…

DC-Based Vaccines for Cancer Immunotherapy

As the sentinels of the immune system, dendritic cells (DCs) play a critical role in initiating and regulating antigen-specific immune responses. Cross-priming, a process that DCs activate CD8 T cells by cross-presenting exogenous antigens onto their MHCI (Major Histocompatibility Complex class I),...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fu, Chunmei, Zhou, Li, Mi, Qing-Sheng, Jiang, Aimin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712957/ https://www.ncbi.nlm.nih.gov/pubmed/33255895 http://dx.doi.org/10.3390/vaccines8040706

Ejemplares similares

DC-Derived Exosomes for Cancer Immunotherapy
por: Yao, Yi, et al.
Publicado: (2021)

Plasmacytoid Dendritic Cells and Cancer Immunotherapy
por: Fu, Chunmei, et al.
Publicado: (2022)

DC-targeting lentivectors for cancer immunotherapy
por: Gea-Mallorquí, Ester, et al.
Publicado: (2023)

Trial watch: Dendritic cell (DC)-based immunotherapy for cancer
por: Laureano, Raquel S, et al.
Publicado: (2022)

Cancer stem cells as targets for DC-based immunotherapy of colorectal cancer
por: Szaryńska, Magdalena, et al.
Publicado: (2018)

DC-based immunotherapy as strategy to purge the HIV reservoir?
por: Søgaard, Ole S.
Publicado: (2019)

DNA vaccine for cancer immunotherapy
por: Yang, Benjamin, et al.
Publicado: (2015)

The Roles of Skin Langerhans Cells in Immune Tolerance and Cancer Immunity
por: Zhou, Li, et al.
Publicado: (2022)

RNA-Based Vaccines in Cancer Immunotherapy
por: McNamara, Megan A., et al.
Publicado: (2015)

Vaccine-Based Immunotherapy for Head and Neck Cancers
por: Beyaert, Simon, et al.
Publicado: (2021)

Identification of Abnormal Data for Synchronous Monitoring of Transformer DC Bias Based on Multiple Criteria
por: Kou, Zhongqing, et al.
Publicado: (2023)

Efficacy of DC-CIK Immunotherapy Combined with Chemotherapy on Locally Advanced Gastric Cancer
por: Liu, Guiyuan, et al.
Publicado: (2022)

Longitudinal analysis of DC subsets in patients with ovarian cancer: Implications for immunotherapy
por: Mastelic-Gavillet, Beatris, et al.
Publicado: (2023)

Assessing the Role of STAT3 in DC Differentiation and Autologous DC Immunotherapy in Mouse Models of GBM
por: Assi, Hikmat, et al.
Publicado: (2014)

Nanoparticle-Based Vaccine Delivery for Cancer Immunotherapy
por: Park, Yeong-Min, et al.
Publicado: (2013)

DC-Based Immunotherapy Combined with Low-Dose Methotrexate Effective in the Treatment of Advanced CIA in Mice
por: Park, Jun-Eui, et al.
Publicado: (2015)

Mycobacteria-Based Vaccines as Immunotherapy for Non-urological Cancers
por: Noguera-Ortega, Estela, et al.
Publicado: (2020)

Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolytics
por: Guo, Zong Sheng, et al.
Publicado: (2019)

Research progress on dendritic cell vaccines in cancer immunotherapy
por: Yu, Jifeng, et al.
Publicado: (2022)

Application of ZnO-Based Nanocomposites for Vaccines and Cancer Immunotherapy
por: Sharma, Prashant, et al.
Publicado: (2019)

Engineering neoantigen vaccines to improve cancer personalized immunotherapy
por: Liu, Zaoqu, et al.
Publicado: (2022)

Does the Immunocompetent Status of Cancer Patients Have an Impact on Therapeutic DC Vaccination Strategies?
por: Martin Lluesma, Silvia, et al.
Publicado: (2018)

Therapeutic cancer vaccines and combination immunotherapies involving vaccination
por: Nguyen, Trang, et al.
Publicado: (2014)

mRNA vaccine for cancer immunotherapy
por: Miao, Lei, et al.
Publicado: (2021)

Digital twin based monitoring and control for DC-DC converters
por: Lei, Zhongcheng, et al.
Publicado: (2023)

Relationship of vaccine efficacy to the kinetics of DC and T-cell responses induced by PLG-based cancer vaccines
por: Ali, Omar A., et al.
Publicado: (2011)

Distinct features of dendritic cell-based immunotherapy as cancer vaccines
por: Lee, Chaelin, et al.
Publicado: (2018)

β-catenin-mediated inhibition of cross-priming: A new mechanism for tumors to evade immunosurveillance
por: Fu, Chunmei, et al.
Publicado: (2013)

Dendritic Cells and CD8 T Cell Immunity in Tumor Microenvironment
por: Fu, Chunmei, et al.
Publicado: (2018)

Bacteria‐Based Cancer Immunotherapy
por: Huang, Xuehui, et al.
Publicado: (2021)

Recent Advances in Cancer Immunotherapy with a Focus on FDA-Approved Vaccines and Neoantigen-Based Vaccines
por: Hargrave, Anna, et al.
Publicado: (2023)

CCL21-DC in situ vaccination in murine NSCLC overcomes resistance to immunotherapy and generates systemic tumor-specific immunity
por: Salehi-Rad, Ramin, et al.
Publicado: (2023)

NK Cell-Based Immunotherapies in Cancer
por: Shin, Min Hwa, et al.
Publicado: (2020)

Cancer Vaccine Immunotherapy with RNA-Loaded Liposomes
por: Sayour, Elias J., et al.
Publicado: (2018)

Tumor lysate-based vaccines: on the road to immunotherapy for gallbladder cancer
por: Rojas-Sepúlveda, Daniel, et al.
Publicado: (2018)

Interleukin 15 in Cell-Based Cancer Immunotherapy
por: Zhou, Yang, et al.
Publicado: (2022)

90K predicts the prognosis of glioma patients and enhances tumor lysate-pulsed DC vaccine for immunotherapy of GBM in vitro
por: Zeng, Yu, et al.
Publicado: (2021)

Strategies for Cancer Immunotherapy Using Induced Pluripotency Stem Cells-Based Vaccines
por: Bernardes de Jesus, Bruno, et al.
Publicado: (2020)

Dendritic Cell (DC) Vaccine in Mouse Lung Cancer Minimal Residual Model; Comparison of Monocyte-derived DC vs. Hematopoietic Stem Cell Derived-DC
por: Baek, Soyoung, et al.
Publicado: (2012)

Dendritic-Cell-Vaccine-Based Immunotherapy for Hepatocellular Carcinoma: Clinical Trials and Recent Preclinical Studies
por: Jeng, Long-Bin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1tlgvfad3km2m13sul5c6uoc9a